• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胃癌的肿瘤内微小隐孢子虫治疗;一项试点研究。

Intra-tumour C. parvum therapy in gastric carcinoma; a pilot study.

作者信息

Dykes P W, Trejdosiewicz L K

出版信息

Dev Biol Stand. 1977;38:547-52.

PMID:608548
Abstract

In a preliminary and toxicological study, eight patients with carcinoma of the stomach were treated by Corynebacterium parvum immunotherapy prior to surgical excision. Killed C. parvum suspension was injected at multiple sites directly into the tumour mass with the aid of fibre-optic gastroscope at doses of 1.5 mg, 4 mg or 8 mg. Each patient received two injections of the same dose with an interval of 14 days. The second injections were made 14 to 18 days prior to surgery. No chemotherapy was administered during this treatment. Patients were monitored clinically for signs of toxicity. Immunological parameters were assessed on peripheral blood samples taken immediately before each injection and prior to surgery. Antibody titre to C. parvum was estimated by direct agglutination, while cell-mediated responses to C. parvum and 3M KCl tumour extract and phytohaemagglutinin (PHA) were assessed by lymphocyte transformation. Serum carcinoembryonic antigen (CEA) was measured by radio-immune assay. Tumours removed at surgery were examined histologically for the presence of invading immunocytes. These preliminary data will be discussed with respect to the dose of C. parvum administered.

摘要

在一项初步毒理学研究中,8例胃癌患者在手术切除前接受了短小棒状杆菌免疫疗法治疗。借助纤维光学胃镜,将灭活的短小棒状杆菌悬液以1.5毫克、4毫克或8毫克的剂量在多个部位直接注入肿瘤块。每位患者接受两次相同剂量的注射,间隔14天。第二次注射在手术前14至18天进行。在此治疗期间未给予化疗。对患者进行临床监测以观察毒性迹象。在每次注射前及手术前采集外周血样本评估免疫参数。通过直接凝集法估计对短小棒状杆菌的抗体滴度,而通过淋巴细胞转化评估对短小棒状杆菌、3M氯化钾肿瘤提取物和植物血凝素(PHA)的细胞介导反应。通过放射免疫测定法测量血清癌胚抗原(CEA)。对手术切除的肿瘤进行组织学检查以确定是否存在浸润性免疫细胞。将结合所给予的短小棒状杆菌剂量对这些初步数据进行讨论。

相似文献

1
Intra-tumour C. parvum therapy in gastric carcinoma; a pilot study.胃癌的肿瘤内微小隐孢子虫治疗;一项试点研究。
Dev Biol Stand. 1977;38:547-52.
2
Intraperitoneal immunotherapy of human ovarian carcinoma with Corynebacterium parvum.短小棒状杆菌对人卵巢癌的腹腔内免疫治疗
Cancer Res. 1983 Mar;43(3):1395-401.
3
Clinical studies with Corynebacterium parvum.微小棒状杆菌的临床研究。
Dev Biol Stand. 1977;38:509-14.
4
In vitro and in vivo effects of Corynebacterium parvum on lymphocyte transformation.短小棒状杆菌对淋巴细胞转化的体外和体内效应
Dev Biol Stand. 1977;38:461-6.
5
Clinical trial with Corynebacterium parvum.
Dev Biol Stand. 1977;38:483-5.
6
Corynebacterium parvum: antibodies measured with the enzyme-linked immunosorbent assay (ELISA) in normal human sera and sera from cancer patients undergoing treatment.微小棒状杆菌:在正常人血清以及接受治疗的癌症患者血清中用酶联免疫吸附测定法(ELISA)检测的抗体。
Ann Immunol (Paris). 1982 Nov-Dec;133D(3):305-11.
7
Moderate to high dose cyclophosphamide and intercalated Corynebacterium parvum in patients with metastatic lung cancer.中高剂量环磷酰胺与小棒状杆菌在转移性肺癌患者中的联合应用
Br J Dis Chest. 1984 Jan;78(1):89-97.
8
Activation of peritoneal lymphocyte cytotoxicity in patients with ovarian cancer by intraperitoneal treatment with Corynebacterium parvum.用短小棒状杆菌腹腔内治疗对卵巢癌患者腹腔淋巴细胞细胞毒性的激活作用。
J Biol Response Mod. 1984 Aug;3(4):371-8.
9
Chemo-immunotherapy of mouse tumours using cyclophosphamide and C. parvum.使用环磷酰胺和微小隐孢子虫对小鼠肿瘤进行化学免疫治疗。
Dev Biol Stand. 1977;38:307-10.
10
The distribution and persistence in vivo of Corynebacterium parvum in relation to its antitumor activity.短小棒状杆菌在体内的分布及持久性与其抗肿瘤活性的关系
Cancer Res. 1977 Jun;37(6):1673-9.

引用本文的文献

1
Lower relapse rates after neighbourhood injection of Corynebacterium parvum in operable cervix carcinoma.可手术宫颈癌患者局部注射短小棒状杆菌后复发率降低。
Br J Cancer. 1981 Dec;44(6):856-62. doi: 10.1038/bjc.1981.284.